Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.88%
After-hours: Aug 15, 2025, 07:31 PM EDT
Spero Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.7M | -13.87M | -20.89M | -17.15M | -17.86M | -12.67M | 51.19M | -3.21M | -11.91M | -13.27M | 26.77M | -11.68M | -28.68M | -32.83M | -29.24M | -22.52M | -18.57M | -19.42M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 2K | n/a | 38K | 108K | 108K | 113K | 129K | 257K | 294K | 189K | 191K | 148K | 148K | 159K |
Stock-Based Compensation | 714K | 1.56M | 1.5M | 2.15M | 2.11M | 2.02M | 2M | 1.91M | 1.86M | 2.17M | 2.5M | 2.11M | 1.32M | 3.2M | 2.93M | 2.33M | 2.16M | 2.01M |
Other Working Capital | n/a | 11.16M | -5.11M | 22.06M | -3.17M | 18.11M | -72.69M | 12.66M | -9.58M | -2.07M | 16.96M | 3.92M | -147K | -5.37M | -775K | 13.25M | 1.62M | -1.15M |
Other Non-Cash Items | -8.67M | 273K | 268K | 263K | 258K | 254K | 249K | 5.55M | 240K | 236K | 93K | 249K | 103K | 2.9M | 1.76M | 228K | 193K | 190K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -154K | 80K | 89K | 45K |
Change in Working Capital | -8.04M | 8.04M | -4.28M | 27.49M | -3.25M | 16.33M | -70.97M | 11.55M | -8.86M | -2.11M | 14.99M | 7.44M | 1.34M | -1.69M | -2.83M | 14.78M | -588K | 1.54M |
Operating Cash Flow | -17.69M | -4M | -23.4M | 12.76M | -18.74M | 5.94M | -17.49M | 15.91M | -18.56M | -12.85M | 44.48M | -957K | -23.03M | -28.22M | -27.35M | -4.95M | -16.57M | -15.48M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -129K | n/a | n/a | n/a | 39K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.97M | n/a | n/a | -26.97M | -30.31M | -1.02M | -9.58M | -3M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 60.78M | n/a | 49.87M | 10.91M | 7M | 18.05M | 20.5M | 6M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 258K | -129K | 50M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33.94M | -129K | 50M | -16.06M | -23.27M | 17.02M | 10.92M | 3M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | -54.25M | 188K | 47.88M | 583K | 168K | 56K |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 220K | n/a | n/a | 14.18M | 6.13M | -53.68M | 3.81M | 50.35M | 29.22M | 168K | 4.31M |
Net Cash Flow | -17.69M | -4M | -23.4M | 12.76M | -18.74M | 5.94M | -17.49M | 16.14M | -18.56M | -12.85M | 58.66M | 5.04M | -26.71M | -40.47M | -275K | 41.3M | -5.48M | -8.17M |
Free Cash Flow | -17.69M | -4M | -23.4M | 12.76M | -18.74M | 5.94M | -17.49M | 15.91M | -18.56M | -12.85M | 44.35M | -957K | -23.03M | -28.22M | -27.31M | -4.95M | -16.57M | -15.48M |